# OnCo record nct07314294 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07314294/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07314294", "NCT07314294" ;
  schema:name "Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients"@en ;
  schema:description "A phase 2 trial of EMB-01 1600 mg administered once weekly throughout the study in colorectal cancer, run by Shanghai EpimAb Biotherapeutics Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07314294/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07314294> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-12-18" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> .